These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1925168)

  • 61. Bioequivalence of single 100-mg doses of two oral formulations of topiramate: an open-label, randomized-sequence, two-period crossover study in healthy adult male Mexican volunteers.
    Piñeyro-López A; Piñeyro-Garza E; Gómez-Silva M; Reyes-Araiza R; Flores-Diego MA; Borrego-Alvarado S; Gamino-Peña ME; Vargas-Zapata R; Salazar-Leal ME
    Clin Ther; 2009 Feb; 31(2):411-7. PubMed ID: 19302913
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Statistical aspects of comparative bioavailability trials.
    Westlake WJ
    Biometrics; 1979 Mar; 35(1):273-80. PubMed ID: 583027
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Bioavailability and bioequivalence of a darunavir 800-mg tablet formulation compared with the 400-mg tablet formulation.
    Kakuda TN; Leopold L; Timmers M; Van De Casteele T; Hillewaert V; Tomaka FL; Hoetelmans RM
    Int J Clin Pharmacol Ther; 2014 Sep; 52(9):805-16. PubMed ID: 25109510
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A new approach for outliers in a bioavailability/bioequivalence study.
    Liao JJ
    J Biopharm Stat; 2007; 17(3):393-405. PubMed ID: 17479389
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Assessment of individual bioequivalence using sufficient bootstrap procedure.
    Beyaztas U
    Pharm Stat; 2019 May; 18(3):388-398. PubMed ID: 30661295
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparative bioavailability and pharmacokinetics of investigational enteric- and film-coated formulations of flurbiprofen 100-mg tablets: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Pakistani male volunteers.
    Ahmad M; Pervaiz F
    Clin Ther; 2010 Mar; 32(3):607-13. PubMed ID: 20399997
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.
    Bustad A; Terziivanov D; Leary R; Port R; Schumitzky A; Jelliffe R
    Clin Pharmacokinet; 2006; 45(4):365-83. PubMed ID: 16584284
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Statistical aspects of bioequivalence testing between two medicinal products.
    Zintzaras E
    Eur J Drug Metab Pharmacokinet; 2005; 30(1-2):41-6. PubMed ID: 16010860
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Eslicarbazepine acetate (BIA 2-093) : relative bioavailability and bioequivalence of 50 mg/mL oral suspension and 200mg and 800mg tablet formulations.
    Fontes-Ribeiro C; Nunes T; Falcão A; Neta C; Lima R; Tavares S; Almeida L; Macedo T; Soares-da-Silva P
    Drugs R D; 2005; 6(5):253-60. PubMed ID: 16128595
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Bioavailability of two oral formulations of a single dose of levofloxacin 500 mg: an open-label, randomized, two-period crossover comparison in healthy Mexican volunteers.
    Galan-Herrera JF; Poo JL; Rosales-Sanchez O; Fuentes-Fuentes E; Cariño L; Burke-Fraga V; Namur S; Parra MG
    Clin Ther; 2009 Aug; 31(8):1796-803. PubMed ID: 19808138
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Two-stage designs versus European scaled average designs in bioequivalence studies for highly variable drugs: Which to choose?
    Molins E; Cobo E; Ocaña J
    Stat Med; 2017 Dec; 36(30):4777-4788. PubMed ID: 28853164
    [TBL] [Abstract][Full Text] [Related]  

  • 72. On a reasonable disaggregate criterion of population bioequivalence admitting of resampling-free testing procedures.
    Wellek S
    Stat Med; 2000 Oct; 19(20):2755-67. PubMed ID: 11033573
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [The bioequivalence of two nifedipine sustained-release formulations after single administration in steady state].
    Meyer FP; Banditt P
    Arzneimittelforschung; 1993 Jun; 43(6):646-50. PubMed ID: 8352817
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparative bioavailability of 2 tablet formulations of levodopa/benserazide in healthy, fasting volunteers: a single-dose, randomized-sequence, open-label crossover study.
    Keller GA; Czerniuk P; Bertuola R; Spatz JG; Assefi AR; Di Girolamo G
    Clin Ther; 2011 Apr; 33(4):500-10. PubMed ID: 21635995
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pharmacokinetics and bioequivalence study of two mosapride citrate formulations after single-dose administration in healthy Chinese male volunteers.
    Huang J; Tian Y; Zhang ZJ; Li J; Cao X
    Arzneimittelforschung; 2011; 61(3):167-72. PubMed ID: 21528641
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Investigation of the bioequivalence of two carbamazepine sustained-release formulations in healthy subjects.
    Schulz HU; Düsing R; Lührmann B; Frercks HJ
    Int J Clin Pharmacol Ther Toxicol; 1992 Oct; 30(10):410-4. PubMed ID: 1446959
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Bioequivalence of tacrolimus formulations with different dynamic solubility and in-vitro dissolution profiles.
    Kwon M; Yeom D; Kim NA; Choi du H; Park J; Wang H; Yoo SD; Jeong SH
    Arch Pharm Res; 2015 Jan; 38(1):73-80. PubMed ID: 24627339
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pharmacokinetics and bioequivalence study of two cetirizine hydrochloride formulations in healthy Chinese male volunteers.
    Xu FG; Liu Y; Zhang ZJ; Tian Y; Chen Y
    Arzneimittelforschung; 2009; 59(9):440-4. PubMed ID: 19856790
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Single-dose relative bioavailability of a new quetiapine fumarate extended-release formulation: a postprandial, randomized, open-label, two-period crossover study in healthy Uruguayan volunteers.
    Estevez-Carrizo FE; Parrillo S; Ercoli MC; Estevez-Parrillo FT
    Clin Ther; 2011 Jun; 33(6):738-45. PubMed ID: 21704238
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Bioequivalence study of two losartan formulations administered orally in healthy male volunteers.
    Bienert A; Brzezińiski R; Szałek E; Dubai V; Grześkowiak E; Dyderski S; Drobnik L; Wolc A; Olejniczak-Rabinek M
    Arzneimittelforschung; 2006; 56(11):723-8. PubMed ID: 17220048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.